Have model transformation languages failed?
Software and Systems Modeling · 2026-06 · 25 (3) · 639-653
DOI: 10.1007/s10270-026-01360-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Software and Systems Modeling, online erschienen am 14.03.2026. Verfasst von Juan de Lara und 2 weiteren Autor:innen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Autónoma de Madrid.
Abstract (Originalsprache)
Model transformation plays an essential role in model-driven engineering. Models need to be transformed into other languages (e.g. for analysis) or rewritten (e.g. for optimisation or simulation). Specialised languages like ATL, ETL or QVT were designed for these tasks and became popular decades ago. However, looking at trends in academic venues and open-source repositories, we observe that their popularity has decayed in the last few years. This paper provides a retrospective on model transformation languages, analyses their current state in scientific venues and development platforms, and discusses possible reasons for their recent decline in popularity. Moreover, in light of current trends in AI-assisted development, we outline new research directions where model transformation languages can play a pivotal role, paving the way for their renewed adoption.
Förderung
- Universidad Autónoma de Madrid
Zitieren
APA
Lara, J. D., Guerra, E., & Cuadrado, J. S. (2026). Have model transformation languages failed?. Software and Systems Modeling, 25(3), 639-653. https://doi.org/10.1007/s10270-026-01360-2
Vancouver
Lara JD, Guerra E, Cuadrado JS. Have model transformation languages failed?. Software and Systems Modeling. 2026;25(3):639-653. doi:10.1007/s10270-026-01360-2
BibTeX
@article{Lara2026,
author = {Lara, Juan de and Guerra, Esther and Cuadrado, Jesús Sánchez},
title = {Have model transformation languages failed?},
journal = {Software and Systems Modeling},
year = {2026},
volume = {25},
number = {3},
pages = {639--653},
doi = {10.1007/s10270-026-01360-2}
}
EUVIMED